CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Fentanyl Citrate

Last Updated: June 30, 2011
Result type: Reports
Project Number: SR0240-000
Product Line: Reimbursement Review

Generic Name: Fentanyl citrate

Brand Name: Abstral

Manufacturer: Paladin Labs Inc.

Therapeutic Area: Pain, breakthrough cancer pain

Indications: Pain, Cancer (breakthrough)

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: December 16, 2011

Recommendation Type: Do not list